Form Type: 4

SEC EDGAR Link
Accession Number:0001415889-22-003935
Date:2022-04-05
Issuer: PTC THERAPEUTICS, INC. (PTCT)
Original Submission Date:

Reporting Person:

BOULDING MARK ELLIOTT
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT SOUTH PLAINFIELD, NJ 07080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-04-05 M 5 a $11.23 61,115 direct
COMMON STOCK 2022-04-05 S 5 d $45.00 61,110 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 11.23 2022-04-05 deemed execution date M 5 (d) 2027-01-02 common stock 5 $11.23 2,276 direct
STOCK OPTION (RIGHT TO BUY) 51.0 deemed execution date 0 ( ) 2025-01-01 common stock 85,600 $51.00 85,600 direct
STOCK OPTION (RIGHT TO BUY) 30.86 deemed execution date 0 ( ) 2026-01-03 common stock 70,000 $30.86 70,000 direct
STOCK OPTION (RIGHT TO BUY) 33.02 deemed execution date 0 ( ) 2029-01-21 common stock 72,500 $33.02 72,500 direct
STOCK OPTION (RIGHT TO BUY) 33.02 deemed execution date 0 ( ) 2029-01-21 common stock 17,500 $33.02 17,500 direct
STOCK OPTION (RIGHT TO BUY) 51.16 deemed execution date 0 ( ) 2030-01-28 common stock 59,500 $51.16 59,500 direct
STOCK OPTION (RIGHT TO BUY) 66.49 deemed execution date 0 ( ) 2031-01-05 common stock 59,500 $66.49 59,500 direct
STOCK OPTION (RIGHT TO BUY) 38.1 deemed execution date 0 ( ) 2032-01-06 common stock 54,000 $38.10 54,000 direct
Footnotes
IDfootnote
f1 this transaction was effected pursuant to a written rule 10b5-1 plan adopted by the reporting person on december 2, 2021.
f2 currently exercisable.
f3 this option was granted on january 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on january 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning april 22, 2020.
f4 this option was granted on january 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on january 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on january 22, 2023.
f5 this option was granted on january 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on january 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on april 29, 2021.
f6 this option was granted on january 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on january 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on april 6, 2022.
f7 this option was granted on january 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on january 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on april 7, 2023.
WhaleWisdom Logo

Elevate your investments